2Smith IE. Overview of gemcitabine activity in advanced breast cancer [J]. Semin Oneol, 2006, 33 ( Suppl 9) : 19S. 被引量:1
3Spielmann M, Llombart - Cussac A, Kalla S, et al. Single -agent gemcitabine is active in previously treated metastatic breast cancer [J]. Oncology, 2001, 60 (4) :303. 被引量:1
4Jamas LA. Phase I studies with the novel nucleoside analog gemcitabine [ J]. Semin Oncol, 1996, 10 (Suppl 23) :25S. 被引量:1
5Modi S, Currie VE, Seidman AD, et al. A phase II trial of gemcitabine in patients with metastatic breast cancer previously treated with an anthracycline and taxane [ J ]. Clin Breast Cancer, 2005, 6 ( 1 ) : 55. 被引量:1
6Valerio MR, Cicero G, Armata MG, et al. Gemcitabine (G) in pretreated breast cancer (BC) [J]. Proc Am Soc Clin Oncol, 2001, 20:51b. 被引量:1
7Rha SY, Moon YH, Jeung HC, et al. Gemcitabine monotherapy as salvage cherootherapy in heavily pretreated metastatic breast cancer [ J ]. Breast Cancer Res Treat, 2005, 90 (3) :215. 被引量:1
8Heinemann V, Stemmler H J, Wohlrab A, et al. High efficacy of gemcitabine and cisplatin in patients with predominantly anthraeycline and taxane pretreated metastatic breast cancer [J]. Cancer Chemother Pharmacot, 2006, 57:640. 被引量:1
9Somali I, Alacacioglu A, Tarhan MO, et al. Cisplatin plus gemcitabine chemotherapy in taxane/anthracycline -resistant metastatic breast cancer [ J ]. Chemotherapy, 2009, 55 (3) : 155. 被引量:1
10[1]Liumbruno G, Centoni PE, Ceretelli S, et al. Rapid reduction of platelet numbers in thrombocytosis[J]. Ther Apher, 2000,4(5):374-376. 被引量:1